TikTok Content Creators Driving Parallel Market for Unlicensed Slimming Medication

A shadow economy for unapproved slimming medications is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Treatment Acquiring Popularity Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers market the substance there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.

Some professionals stated the popularity for the experimental drug could be connected to the increasing cost of licensed slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, legal action or prison.

Service Response and Content Elimination

According to TikTok, the platform has removed violative material and prohibited associated hashtags and query recommendations. The company said it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, populated with photos of slimming results, positive testimonials and detailed guides for mixing or administering at home.

Within minutes of entering one group, a vendor shared WhatsApp details, where most transactions occur. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, health issues or previous experience.

Product Information and Pricing

Within these communities, posts show black plastic packages with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors typically sold at £160 for 20mg. When asked how long a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service said it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has previously seen patients injured by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious medical dangers”.

Brett Richmond
Brett Richmond

A digital strategist with over a decade of experience in content marketing and SEO, specializing in helping UK businesses enhance their online presence.